In fact, we have previously shown that UBE2C silencing in two ESCC-derived cell lines leads to a decrease in cell proliferation rates and alters cell cycle profile, by interfering with cyclin B1 levels [10]. Here, UBE2C is linked to esophageal squamous cell carcinoma.